StonvexLoading…
StonvexStonvexStonvexCore line items from CBL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $16.24M | $18.57M | $18.88M | $17.85M |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $135.97M | $58.97M | $6.55M | $-93.48M |
EPS (Diluted) | $4.34 | $1.87 | $0.17 | $-3.20 |
Total Assets | $2.73B | $2.75B | $2.41B | $2.68B |
Total Liabilities | $2.36B | $2.43B | $2.08B | $2.31B |
Cash & Equivalents | $42.29M | $40.79M | $34.19M | $44.72M |
Free Cash Flow OCF − CapEx | Not available | Not available | $141.25M | $165.29M |
Shares Outstanding | 30.32M | 30.71M | 31.98M | 31.78M |